πŸ”₯πŸ” BizChicken πŸ”πŸ”₯

Companies Similar to GeneDx Holdings Corp.

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

Bio-Path Holdings, Inc.

Bio-Path Holdings, Inc. logo
Market Cap: Lowest
Employees: Lowest

DNAbilize

Bio-Path Holdings, Inc. is a clinical and preclinical stage oncology focused RNAi nano particle drug development company, developing products based on the DNAbilize technology. The company is advancing its lead drug candidate, prexigebersen, for the treatment of AML and myelodysplastic syndrome.

Tags: Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia, DNAbilize, Drug Development, Lymphoma, Myelodysplastic Syndrome, Oncology, Pancreatic Cancer, Prexigebersen, RNAi

Symbol: BPTH

Recent Price: $1.17

Industry: Biotechnology

CEO: Mr. Peter H. Nielsen MBA

Sector: Healthcare

Employees: 10

Address: 4710 Bellaire Boulevard, Bellaire, TX 77401

Phone: 832 742 1357

Leadership

  • Peter Nielsen, Chief Executive Officer, Chief Financial Officer
  • Ana Tari Ashizawa, PhD, MBA, Senior Vice President of Research, Development & Clinical Design
  • Anthony Price, MBA, Senior Vice President of Finance, Accounting & Administration
  • Michael Hickey, MBA, Vice President of Clinical Operations
  • Michael Roberts, Director of Manufacturing Planning & Engineering
  • Chairman of the Board,
  • President,
  • Heath Cleaver, Director
  • Paul Aubert, Director
  • Douglas P. Morris, Director
  • Aline Sherwood, Director

Last updated: 2024-12-31

Health Catalyst, Inc.

Health Catalyst, Inc. logo
Market Cap: Medium
Employees: Medium

Data and Analytics Platform

Health Catalyst provides data and analytics technology and services to healthcare organizations, facilitating AI integration, population health management, financial transformation, quality and safety improvement, and a national data ecosystem.

Tags: AI, data analytics, financial transformation, healthcare, patient safety, population health management, quality improvement

Symbol: HCAT

Recent Price: $7.01

Industry: Medical - Healthcare Information Services

CEO: Mr. Daniel D. Burton

Sector: Healthcare

Employees: 1300

Address: 10897 South River Front Parkway, South Jordan, UT 84095

Phone: 801 708 6800

Last updated: 2024-12-31

GE HealthCare Technologies Inc.

GE HealthCare Technologies Inc. logo
Market Cap: Highest
Employees: Highest

Healthcare products and digital solutions

GE Health Care Technologies Inc. develops, manufactures, and markets products, services, and digital solutions for patient diagnosis, treatment, and monitoring globally. It operates through segments including Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.

Tags: Diagnostics, Healthcare, Imaging, Medical Devices, Ultrasound

Symbol: GEHC

Recent Price: $78.60

Industry: Medical - Healthcare Information Services

CEO: Mr. Peter J. Arduini

Sector: Healthcare

Employees: 51000

Address: 500 West Monroe Street, Chicago, IL 60661

Phone: 617 443 3400

Last updated: 2024-12-31

Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp. logo
Market Cap: Lowest
Employees: Low

TNX-1500, TNX-2900, TNX-801, TNX-1840, TNX-1850, TNX-3500

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company that focuses on developing therapies for immunology, rare diseases, infectious diseases, and central nervous system disorders. Key products include TNX-1500 for organ transplant and autoimmune diseases, TNX-2900 for Prader-Willi syndrome, and TNX-801 for smallpox prevention.

Tags: CNS, autoimmunity, biopharmaceutical, cancer, immunology, infectious disease, rare disease, therapeutics

Symbol: TNXP

Recent Price: $0.36

Industry: Biotechnology

CEO: Dr. Seth Lederman M.D.

Sector: Healthcare

Employees: 103

Address: 26 Main Street, Chatham, NJ 07928

Phone: 862 799 8599

Last updated: 2024-12-31

GeneDx Holdings Corp.

GeneDx Holdings Corp. logo
Market Cap: High
Employees: Medium

Centrellis health intelligence platform

Gene Dx Holdings Corp. is a patient-centered health intelligence company focused on transforming healthcare by leveraging AI and machine learning on clinical and genomic data to improve individual health outcomes.

Tags: AI, genomics, health intelligence, healthcare, machine learning

Symbol: WGS

Recent Price: $76.58

Industry: Medical - Healthcare Information Services

CEO: Ms. Katherine A. Stueland

Sector: Healthcare

Employees: 1000

Address: North Tower, Stamford, CT 06902

Phone: 800 298 6470

Last updated: 2024-12-31

ALX Oncology Holdings Inc.

ALX Oncology Holdings Inc. logo
Market Cap: Low
Employees: Low

ALX148

ALX Oncology Holdings Inc. is a clinical-stage immuno-oncology company developing therapies for cancer patients. Its lead product, ALX148, targets CD47 and is in trials for various cancers. The company also explores pre-clinical treatments like ALTA-002 to enhance immune response to cancer.

Tags: CD47, cancer therapy, clinical trials, collaboration, immuno-oncology, solid tumors

Symbol: ALXO

Recent Price: $1.66

Industry: Biotechnology

CEO: Mr. Jason W. Lettmann

Sector: Healthcare

Employees: 81

Address: 323 Allerton Avenue, South San Francisco, CA 94080

Phone: 650 466 7125

Last updated: 2024-12-31

Cardio Diagnostics Holdings, Inc.

Cardio Diagnostics Holdings, Inc. logo
Market Cap: Lowest
Employees: Lowest

Epi+Gen CHD

Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease, offering products like Epi+Gen CHD to assess risk and personalize care using AI and precision epigenetics.

Tags: AI, Cardiovascular Disease, Clinical Tests, Epigenetics, Healthcare, Precision Medicine

Symbol: CDIO

Recent Price: $0.82

Industry: Biotechnology

CEO: Dr. Meeshanthini V. Dogan Ph.D.

Sector: Healthcare

Employees: 7

Address: 400 N Aberdeen St, Chicago, IL 60642

Phone: 855 226 9991

Last updated: 2024-12-31

Celcuity Inc.

Celcuity Inc. logo
Market Cap: Medium
Employees: Lowest

CELsignia diagnostic platform

Celcuity Inc., a biotechnology company, develops targeted therapies for cancer patients in the US, including the CELsignia diagnostic platform and Gedatolisib drug candidate.

Tags: Gedatolisib, HER2-negative, biotechnology, breast cancer, cancer therapy, diagnostic platform

Symbol: CELC

Recent Price: $13.13

Industry: Biotechnology

CEO: Mr. Brian F. Sullivan

Sector: Healthcare

Employees: 55

Address: 16305–36th Avenue North, Minneapolis, MN 55446

Phone: 763 392 0767

Leadership

  • Brian Sullivan, CEO and Co-founder
  • Lance Laing, PhD, Chief Science Officer and Co-founder
  • Vicky Hahne, CFO
  • Igor Gorbatchevsky, MD, Chief Medical Officer
  • Eldon Mayer, Chief Commercial Officer
  • Brent Eilefson, General Counsel
  • Bernhard Lampert, PhD, VP of Pharmaceutical Development
  • Nadene Zack, VP Clinical Operations
  • Sunni Miller, VP of Regulatory Affairs
  • David Bridge, VP of Quality Assurance and Process Development
  • William Strickland, PharmD, VP of Medical Affairs
  • Fred Kerwood, VP of Program Management
  • Charlotte Moser, MD, PhD, SVP of Clinical Development
  • John R. MacDonald, PhD, SVP of R&D
  • Lance Laing, PhD, Chief Science Officer and Co-Founder
  • Richard Buller, MD, PhD, Director
  • David F. Dalvey, Director
  • Leo Furcht, MD, Director
  • Polly Murphy, DVM, PhD, Director
  • Richard J. Nigon, Director

Last updated: 2024-12-31

4D Molecular Therapeutics, Inc.

4D Molecular Therapeutics, Inc. logo
Market Cap: Medium
Employees: Low

4D-125, 4D-110, 4D-310, 4D-150, 4D-710

4D Molecular Therapeutics, Inc. is a clinical-stage gene therapy company developing product candidates using adeno-associated virus vectors, focusing on ophthalmology, cardiology, and pulmonology.

Tags: biotechnology, cardiology, gene therapy, ophthalmology, pulmonology

Symbol: FDMT

Recent Price: $5.30

Industry: Biotechnology

CEO: Dr. David H. Kirn M.D.

Sector: Healthcare

Employees: 201

Address: 5858 Horton Street, EmeryVille, CA 94608

Phone: 510 505 2680

Last updated: 2024-12-31

Lexeo Therapeutics, Inc. Common Stock

Lexeo Therapeutics, Inc. Common Stock logo
Market Cap: Low
Employees: Low

LX2006, LX2020, LX2021, LX2022, LX1001, LX1020, LX1021, LX1004

Lexeo Therapeutics is a clinical-stage genetic medicine company developing innovative gene therapy candidates targeting hereditary and acquired diseases, including cardiomyopathies and neurological conditions.

Tags: APOE4, Batten disease, acquired diseases, cardiomyopathy, gene therapy, genetic medicine, hereditary diseases

Symbol: LXEO

Recent Price: $6.54

Industry: Biotechnology

CEO: Mr. R. Nolan Townsend

Sector: Healthcare

Employees: 69

Address: 345 Park Avenue South, New York, null 10010

Phone: 212-547-9879

Last updated: 2024-12-31

Nurix Therapeutics, Inc.

Nurix Therapeutics, Inc. logo
Market Cap: High
Employees: Low

NX-2127, NX-5948, NX-1607, NX-0255

Nurix Therapeutics, Inc. is a biopharmaceutical company that focuses on developing small molecule therapies for cancer and immune disorders, with products targeting BTK and CBL-B proteins. The company collaborates with Gilead Sciences and Sanofi.

Tags: BTK degrader, CBL-B inhibitor, biopharmaceutical, cancer, clinical trials, immune disorders

Symbol: NRIX

Recent Price: $18.64

Industry: Biotechnology

CEO: Dr. Arthur T. Sands M.D., Ph.D.

Sector: Healthcare

Employees: 284

Address: 1700 Owens Street, San Francisco, CA 94158

Phone: 415 660 5320

Last updated: 2024-12-31

Personalis, Inc.

Personalis, Inc. logo
Market Cap: Low
Employees: Low

NeXT Platform

Personalis, Inc. is a cancer genomics company that provides sequencing and data analysis services for cancer therapy development and genetic research. Their products include NeXT Platform, NeXT Liquid Biopsy, NeXT Personal, NeXT Dx Test, and ACE platform, serving biopharmaceutical, academic, and government institutions.

Tags: cancer genomics, data analysis, personalized therapy, sequencing, tumor profiling

Symbol: PSNL

Recent Price: $5.97

Industry: Medical - Diagnostics & Research

CEO: Mr. Christopher M. Hall

Sector: Healthcare

Employees: 223

Address: 1330 O’Brien Drive, Menlo Park, CA 94025

Phone: 650 752 1300

Last updated: 2024-12-31

Quanterix Corporation

Quanterix Corporation logo
Market Cap: Medium
Employees: Medium

HD-X, SR-X, SP-X instruments

Quanterix Corporation develops and markets digital immunoassay platforms to advance precision health in life sciences research and diagnostics globally, offering products like the HD-X, SR-X, and SP-X instruments, assay kits, and providing contract research services across areas such as neurology, oncology, and cardiology.

Tags: HD-X, SP-X, SR-X, Simoa technology, cardiology, digital immunoassay, life sciences, neurology, oncology, precision health

Symbol: QTRX

Recent Price: $10.90

Industry: Medical - Devices

CEO: Dr. Masoud Toloue Ph.D.

Sector: Healthcare

Employees: 441

Address: Building 1, Billerica, MA 01821

Phone: 617 301 9400

Last updated: 2024-12-31

Scopus BioPharma Inc.

Scopus BioPharma Inc. logo
Market Cap: Lowest
Employees: Lowest

Duet Platform

Scopus Bio Pharma Inc., a clinical-stage biopharmaceutical company, focuses on developing transformational therapeutics for serious diseases with lead programs in immuno-oncology gene therapy.

Tags: biopharmaceutical, cancer treatment, gene therapy, immuno-oncology, therapeutics

Symbol: SCPS

Recent Price: $0.00

Industry: Biotechnology

CEO: Dr. Alan D. Horsager Ph.D.

Sector: Healthcare

Employees: 13

Address: 420 Lexington Avenue, New York, NY 10170

Phone: 212 479 2513

Last updated: 2024-12-31

Ginkgo Bioworks Holdings, Inc.

Ginkgo Bioworks Holdings, Inc. logo
Market Cap: Medium
Employees: Medium

platform for cell programming

Ginkgo Bioworks Holdings, Inc. develops a platform used to program cells for biological production of products such as therapeutics, food ingredients, and chemicals. It serves markets in specialty chemicals, agriculture, food, consumer products, and pharmaceuticals.

Tags: agriculture, biotechnology, cell programming, food ingredients, novel therapeutics, pharmaceuticals, specialty chemicals

Symbol: DNA

Recent Price: $9.44

Industry: Biotechnology

CEO: Dr. Jason Kelly

Sector: Healthcare

Employees: 1218

Address: 27 Drydock Avenue, Boston, MA 02210

Phone: 877 422 5362

Last updated: 2024-12-31

Grid Dynamics Holdings, Inc.

Grid Dynamics Holdings, Inc. logo
Market Cap: Medium
Employees: High

Enterprise-Level Digital Transformation Services

Grid Dynamics Holdings, Inc. provides enterprise-level digital transformation services, including search, analytics, and release automation, for Fortune 1000 corporations worldwide. They offer strategy consulting, prototypes, and delivery of digital platforms.

Tags: Fortune 1000, analytics, consulting, digital transformation, release automation, software design

Symbol: GDYN

Recent Price: $22.50

Industry: Information Technology Services

CEO: Mr. Leonard Livschitz

Sector: Technology

Employees: 4298

Address: 5000 Executive Parkway, San Ramon, CA 94583

Phone: 650 523 5000

Leadership

  • Tijana, Delivery Manager
  • Anderson, Software Engineer
  • Alex, Principal Data Scientist
  • Grid Dynamics, Company

Last updated: 2024-12-31

Galecto, Inc.

Galecto, Inc. logo
Market Cap: Lowest
Employees: Lowest

GB2064

Galecto, Inc. is a clinical-stage biotechnology company focused on developing molecules for the treatment of fibrosis, cancer, inflammation, and related diseases. Their lead product candidate, GB2064, is in Phase IIa for myelofibrosis. The company also advances other candidates targeting severe fibrotic lung diseases and cancer.

Tags: biotechnology, cancer, clinical trials, fibrosis, inflammation, pharmaceutical

Symbol: GLTO

Recent Price: $4.60

Industry: Biotechnology

CEO: Dr. Hans T. Schambye M.D., Ph.D.

Sector: Healthcare

Employees: 13

Address: 75 State Street, Boston, MA 02109

Phone: 457 070 5210

Last updated: 2024-12-31

Lantheus Holdings, Inc.

Lantheus Holdings, Inc. logo
Market Cap: Highest
Employees: Medium

DEFINITY, Techne Lite, Xenon-133, Neurolite, Cardiolite, Thallium-201, Gallium-67, AZEDRA, Automated Bone Scan Index, Cobalt (Co 57), RELISTOR

Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide.

Tags: cardiovascular, diagnostic products, healthcare, oncology, radiotherapy, therapeutic products

Symbol: LNTH

Recent Price: $89.13

Industry: Drug Manufacturers - Specialty & Generic

CEO: Mr. Brian A. Markison

Sector: Healthcare

Employees: 834

Address: 331 Treble Cove Road, North Billerica, MA 01862

Phone: 978 671 8001

Leadership

  • Brian Markison, Chief Executive Officer
  • Paul Blanchfield, President
  • Jeff Humphrey, MD, Chief Medical Officer
  • Robert J. Marshall Jr., Chief Financial Officer
  • Amanda Morgan, Chief Commercial Officer
  • Daniel Niedzwiecki, Chief Administrative Officer, General Counsel and Corporate Secretary
  • Jean-Claude Provost, MD, Chief Science Officer
  • Jamie Spaeth, Chief People Officer
  • Cheryl Ball, Senior Vice President, Strategy and Enterprise Planning
  • Dorothy Barr, Senior Vice President, Manufacturing and Technical Operations
  • Kim Brown, Chief Accounting Officer
  • Lee Anne Howe, Chief Information Officer
  • Linda Lennox, Chief of Staff & Vice President, Corporate Communications
  • Joann Nestor, Senior Vice President, Legal Affairs
  • Andrea Sabens, Vice President, Business Optimization
  • Carol Walker, Senior Vice President, Quality
  • Mary Anne Heino, Chairperson of the Board
  • Minnie Baylor-Henry, Director
  • GΓ©rard Ber, PhD, Director
  • Julie Eastland, Director
  • Samuel Leno, Director
  • Heinz MΓ€usli, Director
  • Julie McHugh, Director
  • Gary J. Pruden, Director
  • James H. Thrall, MD, Director

Last updated: 2024-12-31

MeiraGTx Holdings plc

MeiraGTx Holdings plc logo
Market Cap: Low
Employees: Medium

Gene Therapy Treatments

Meira GTx Holdings plc is a clinical stage gene therapy company developing treatments for serious diseases, including ocular diseases, xerostomia, and neurodegenerative conditions. They are in various stages of clinical development for several gene therapy programs and have a research collaboration with Janssen Pharmaceuticals.

Tags: Clinical Stage, Gene Therapy, Neurodegenerative Diseases, Ocular Diseases, Research Collaboration, Xerostomia

Symbol: MGTX

Recent Price: $5.89

Industry: Biotechnology

CEO: Dr. Alexandria Forbes Ph.D.

Sector: Healthcare

Employees: 387

Address: 430 East 29th Street, New York, NY 10016

Phone: 646 860 7985

Leadership

  • Alexandria Forbes, Ph.D., Board Member, President and Chief Executive Officer
  • Richard Giroux, Chief Operating Officer and Chief Financial Officer
  • Stuart Naylor, Ph.D., Chief Development Officer
  • Robert K. Zeldin, M.D., Chief Medical Officer
  • Robert Wollin, JD, General Counsel and Secretary
  • Alastair Leighton, Ph.D, SVP, Manufacturing and Supply Chain
  • Christine Sheehy, SVP, Global Integration
  • Tim Randall, SVP, Risk and Internal Controls
  • Michel Michaelides, M.D., Head of Clinical Ophthalmology
  • Tassos Georgiadis, Ph.D., Vice President, Preclinical Development
  • Keith R. Harris, Ph.D., Chairman of the Board
  • Ellen Hukkelhoven, Ph.D., Board Member
  • Lord Mendoza, Independent Board Member
  • Nicole Seligman, Independent Board Member
  • Thomas E. Shenk, Ph.D., Independent Board Member
  • Debra Yu, M.D., Independent Board Member

Last updated: 2024-12-31

Zeta Global Holdings Corp.

Zeta Global Holdings Corp. logo
Market Cap: Highest
Employees: High

Zeta Marketing Platform

Zeta Global Holdings Corp. provides an omnichannel data-driven cloud platform for consumer intelligence and marketing automation, utilizing machine learning algorithms to analyze data and predict consumer intent.

Tags: cloud platform, consumer intelligence, data analysis, machine learning, marketing automation, omnichannel

Symbol: ZETA

Recent Price: $18.06

Industry: Software - Application

CEO: Mr. David A. Steinberg

Sector: Technology

Employees: 1783

Address: 3 Park Avenue, New York, NY 10016

Phone: 212 967 5055

Leadership

  • David A. Steinberg, Co-Founder, Chairman, CEO
  • John Sculley, Co-Founder, Vice Chairman and Director
  • Steven Gerber, President and Chief Operating Officer
  • Christopher Greiner, Chief Financial Officer
  • Steve Vine, EVP of Mergers and Acquisitions and General Counsel
  • Candice Chafey, Chief People Officer
  • Christian Monberg, Chief Technology Officer and Head of Product
  • Neej Gore, Chief Data Officer
  • Will Margiloff, Chief Growth Officer
  • Kelly Kennedy, Chief Revenue Officer of CRM
  • Matthew Mobley, President of Zeta CRM
  • Jed Hartman, President of Activation Partnerships
  • Dr. Jeffry Nimeroff, Chief Information Officer
  • Narendra Amarineni, President of Zeta Actions
  • Tina McCain, EVP, Client Partnerships
  • Rob Lentz, EVP of Enterprise Operations
  • Bharat Goyal, EVP and Head of Engineering
  • Harrison Davies, President of Media Activation
  • Bryan Seltzer, President, ZX
  • Kurt Baumgarten, CISO and VP, Information Security
  • Benjamin Hayes, SVP, Privacy & Chief Privacy Officer
  • Kara Trivunovic, SVP, Strategic Solutions
  • Yara Lutz, SVP, Customer Success

Last updated: 2024-12-31